Marlborough, Massachusetts--(Newsfile Corp. - October 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP...
HACKENSACK, NJ/ ACCESSWIRE / October 1, 2024 / Royal Wound-X, a division of Royal Biologics, is proud to announce that...
Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of...
DUBAI, UAE / ACCESSWIRE / October 1, 2024 / Patient outcomes are being revolutionized by cutting-edge technologies and advanced physiotherapy...
Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of...
With Amazon's market value increasing by more than $400 billion in 2024, CBD Life Sciences Inc. is poised for new...
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding...
The Health and Fitness Summit is hosted by MEFITPRO, the leading distributor of best-in-class brands in the Gulf regionGulf countries...
SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Merakris to showcase new Lyophilized Amnion Chorion Allograft at the Fall Symposium for Advanced Wound Care (SAWC) in Las Vegas...
Nantahala to nominate 2 board seats Portion of the proceeds received from warrants executed at $8.16/share SOLANA BEACH, Calif., Oct....
Proceeds from second draw used to pay down higher interest Michigan debtTORONTO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp....
NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...
This first-to-market launch showcases Teva’s proven strengths in complex generic formulations and enhances Teva’s strategic goal of sustaining a generic...
Jeffrey Knudson to Step Down as CFO Following Company’s Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO...
CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical...
Noom Appoints Olcott to Advance Noom Med Programming Following Newly Launched GLP-1Rx Solution NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) --...
BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung...